Diagnosis and treatment of cardiovascular manifestations of COVID-19: a narrative review

References

• WHO COVID-19 dashboard. Geneva: World Health Organization; 2020.
   Google Scholar
• Shiels MS, Haque AT, Berrington de González A, et al. Leading causes of death in the US during the COVID-19 pandemic, March 2020 to October 2021. JAMA Intern Med. 2022;182(8):883–886. doi: 10.1001/jamainternmed.2022.2476.
   PubMed Web of Science ®Google Scholar
• Soneji S, Beltrán-Sánchez H, Yang JW, et al. Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America. Genus. 2021;77(1):7. doi: 10.1186/s41118-021-00115-9.
   PubMedGoogle Scholar
• Alexander LK, Small JD, Edwards S, et al. An experimental model for dilated cardiomyopathy after rabbit coronavirus infection. J Infect Dis. 1992;166(5):978–985. doi: 10.1093/infdis/166.5.978.
   PubMed Web of Science ®Google Scholar
• Kite TA, Pallikadavath S, Gale CP, et al. The direct and indirect effects of COVID-19 on acute coronary syndromes. Cardiol Clin. 2022;40(3):309–320. doi: 10.1016/j.ccl.2022.03.002.
   PubMed Web of Science ®Google Scholar
• Zuin M, Rigatelli G, Bilato C, et al. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis. Acta Cardiol. 2022;77(2):107–113. doi: 10.1080/00015385.2021.1890925.
   PubMed Web of Science ®Google Scholar
• Dewland TA, Whitman IR, Win S, et al. Prospective arrhythmia surveillance after a COVID-19 diagnosis. Open Heart. 2022;9(1):e001758. doi: 10.1136/openhrt-2021-001758.
   PubMed Web of Science ®Google Scholar
• Ammirati E, Lupi L, Palazzini M, et al. Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis. Circulation. 2022;145(15):1123–1139. doi: 10.1161/CIRCULATIONAHA.121.056817.
   PubMed Web of Science ®Google Scholar
• Shah RM, Shah M, Shah S, et al. Takotsubo syndrome and COVID-19: associations and implications. Curr Probl Cardiol. 2021;46(3):100763. doi: 10.1016/j.cpcardiol.2020.100763.
   PubMed Web of Science ®Google Scholar
• Acharya P, Ranka S, Sethi P, et al. Incidence, predictors, and outcomes of in-hospital cardiac arrest in COVID-19 patients admitted to intensive and non-intensive care units: insights from the AHA COVID-19 CVD Registry. J Am Heart Assoc. 2021;10(16):e021204.
   PubMed Web of Science ®Google Scholar
• Yalcin HC, Sukumaran V, Al-Ruweidi MKAA, et al. Do changes in ACE-2 expression affect SARS-CoV-2 virulence and related complications: a closer look into membrane-bound and soluble forms. Int J Mol Sci. 2021;22(13):6703.
   PubMed Web of Science ®Google Scholar
• Medina-Barandica J, Contreras-Puentes N, Tarón-Dunoyer A, et al. In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2. Inform Med Unlocked. 2023;40:101278. doi: 10.1016/j.imu.2023.101278.
   PubMedGoogle Scholar
• European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up. Eur Heart J. 2022;43(18):1776.
   Web of Science ®Google Scholar
• Williams B, Zhang Y. Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19. Lancet. 2020;395(10238):1671–1673. doi: 10.1016/S0140-6736(20)31131-4.
   PubMed Web of Science ®Google Scholar
• Singh S, Offringa-Hup AK, Logtenberg SJJ, et al. Discontinuation of antihypertensive medications on the outcome of hospitalized patients with severe acute respiratory syndrome-coronavirus 2. Hypertension. 2021;78(1):165–173. doi: 10.1161/HYPERTENSIONAHA.121.17328.
   PubMed Web of Science ®Google Scholar
• Gauchotte G, Venard V, Segondy M, et al. SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study. Int J Legal Med. 2021;135(2):577–581. doi: 10.1007/s00414-020-02500-z.
   PubMed Web of Science ®Google Scholar
• Otifi HM, Adiga BK. Endothelial dysfunction in Covid-19 infection. Am J Med Sci. 2022;363(4):281–287. doi: 10.1016/j.amjms.2021.12.010.
   PubMed Web of Science ®Google Scholar
• Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–e582. doi: 10.1016/S2352-3026(20)30216-7.
   PubMed Web of Science ®Google Scholar
• Wolf A, Khimani F, Yoon B, et al. The mechanistic basis linking cytokine storm to thrombosis in COVID-19. Thrombosis Update. 2022;8:100110. doi: 10.1016/j.tru.2022.100110.
   PubMedGoogle Scholar
• Imazio M, Brucato A, Lazaros G, et al. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality. J Cardiovasc Med. 2020;21(9):625–629. doi: 10.2459/JCM.0000000000001059.
   Google Scholar
• Kariyanna PT, Chandrakumar HP, Jayarangaiah A, et al. Apical takotsubo cardiomyopathy in a COVID-19 patient presenting with stroke: a case report and pathophysiologic insights. Am J Med Case Rep. 2020;8(10):350–357.
   Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. doi: 10.1001/jamacardio.2020.1017.
   PubMed Web of Science ®Google Scholar
• Etheridge SP, Asaki SY. COVID-19 infection and corrected QT interval prolongation-collateral damage from our newest enemy. JAMA Netw Open. 2021;4(4):e217192. doi: 10.1001/jamanetworkopen.2021.7192.
   PubMed Web of Science ®Google Scholar
• Katsoularis I, Fonseca-Rodríguez O, Farrington P, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599–607. doi: 10.1016/S0140-6736(21)00896-5.
   PubMed Web of Science ®Google Scholar
• Modin D, Claggett B, Sindet-Pedersen C, et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142(21):2080–2082. doi: 10.1161/CIRCULATIONAHA.120.050809.
   PubMed Web of Science ®Google Scholar
• Rashid M, Wu J, Timmis A, et al. Outcomes of COVID-19-positive acute coronary syndrome patients: a multisource electronic healthcare records study from England. J Intern Med. 2021;290(1):88–100. doi: 10.1111/joim.13246.
   PubMed Web of Science ®Google Scholar
• Alvarez-Garcia J, Lee S, Gupta A, et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. J Am Coll Cardiol. 2020;76(20):2334–2348. doi: 10.1016/j.jacc.2020.09.549.
   PubMed Web of Science ®Google Scholar
• Li Z, Shao W, Zhang J, et al. Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:720129. doi: 10.3389/fcvm.2021.720129.
   PubMed Web of Science ®Google Scholar
• Tan Z, Huang S, Mei K, et al. The prevalence and associated death of ventricular arrhythmia and sudden cardiac death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:795750. doi: 10.3389/fcvm.2021.795750.
   PubMed Web of Science ®Google Scholar
• Coromilas EJ, Kochav S, Goldenthal I, et al. Worldwide survey of COVID-19-associated arrhythmias. Circ Arrhythm Electrophysiol. 2021;14(3):e009458.
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk, and inflammation: mind the gap! Circulation. 2020;142(1):7–9. doi: 10.1161/CIRCULATIONAHA.120.047293.
   PubMed Web of Science ®Google Scholar
• Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021;6(9):1078–1087. doi: 10.1001/jamacardio.2021.2065.
   PubMed Web of Science ®Google Scholar
• Kawakami R, Sakamoto A, Kawai K, et al. Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol. 2021;77(3):314–325. doi: 10.1016/j.jacc.2020.11.031.
   PubMed Web of Science ®Google Scholar
• Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861–1862. doi: 10.1093/eurheartj/ehaa286.
   PubMed Web of Science ®Google Scholar
• Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M. Pericarditis in patients with COVID-19: a systematic review. J Cardiovasc Med. 2021;22(9):693–700. doi: 10.2459/JCM.0000000000001202.
   Google Scholar
• Virani SS, Nasser Khan A, Mendoza CE, et al. Takotsubo cardiomyopathy, or broken-heart syndrome. Tex Heart Inst J. 2007;34(1):76–79.
   PubMed Web of Science ®Google Scholar
• John K, Lal A, Mishra A. A review of the presentation and outcome of takotsubo cardiomyopathy in COVID-19. Monaldi Arch Chest Dis. 2021;91(3). doi: 10.4081/monaldi.2021.1710.
   Google Scholar
• Giustino G, Croft LB, Oates CP, et al. Takotsubo cardiomyopathy in COVID-19. J Am Coll Cardiol. 2020;76(5):628–629. doi: 10.1016/j.jacc.2020.05.068.
   PubMed Web of Science ®Google Scholar
• Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196. doi: 10.1016/j.chest.2020.11.005.
   PubMed Web of Science ®Google Scholar
• Suh YJ, Hong H, Ohana M, et al. Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology. 2021;298(2):E70–E80. doi: 10.1148/radiol.2020203557.
   PubMed Web of Science ®Google Scholar
• Kollias A, Kyriakoulis KG, Lagou S, et al. Venous thromboembolism in COVID-19: a systematic review and meta-analysis. Vasc Med. 2021;26(4):415–425. doi: 10.1177/1358863X21995566.
   PubMed Web of Science ®Google Scholar
• Sandoval Y, Januzzi JL Jr., Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244–1258. doi: 10.1016/j.jacc.2020.06.068.
   PubMed Web of Science ®Google Scholar
• Wibowo A, Pranata R, Akbar MR, et al. Prognostic performance of troponin in COVID-19: a diagnostic meta-analysis and meta-regression. Int J Infect Dis. 2021;105:312–318. doi: 10.1016/j.ijid.2021.02.113.
   PubMed Web of Science ®Google Scholar
• Majure DT, Gruberg L, Saba SG, et al. Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury. Am J Cardiol. 2021;138:100–106. doi: 10.1016/j.amjcard.2020.09.060.
   PubMed Web of Science ®Google Scholar
• Velavan TP, Kuk S, Linh LTK, et al. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients. Sci Rep. 2021;11(1):14471. doi: 10.1038/s41598-021-93950-x.
   PubMed Web of Science ®Google Scholar
• Cunningham JW, Claggett BL, Jering KS, et al. Prognostic value of natriuretic peptides and cardiac troponins in COVID-19. Circulation. 2021;144(2):177–179. doi: 10.1161/CIRCULATIONAHA.121.054969.
   PubMed Web of Science ®Google Scholar
• Iorio A, Lombardi CM, Specchia C, et al. Combined role of troponin and natriuretic peptides measurements in patients with COVID-19 (from the Cardio-COVID-Italy Multicenter Study). Am J Cardiol. 2022;167:125–132. doi: 10.1016/j.amjcard.2021.11.054.
   PubMed Web of Science ®Google Scholar
• Gorog DA, Storey RF, Gurbel PA, et al. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol. 2022;19(7):475–495. doi: 10.1038/s41569-021-00665-7.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–2973. doi: 10.1016/j.jacc.2020.04.031.
   PubMed Web of Science ®Google Scholar
• Varikasuvu SR, Varshney S, Dutt N, et al. D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies. Sci Rep. 2021;11(1):21888. doi: 10.1038/s41598-021-01462-5.
   PubMed Web of Science ®Google Scholar
• Long B, Brady WJ, Bridwell RE, et al. Electrocardiographic manifestations of COVID-19. Am J Emerg Med. 2021;41:96–103. doi: 10.1016/j.ajem.2020.12.060.
   PubMed Web of Science ®Google Scholar
• De Carvalho H, Leonard-Pons L, Segard J, et al. Electrocardiographic abnormalities in COVID-19 patients visiting the emergency department: a multicenter retrospective study. BMC Emerg Med. 2021;21(1):141. doi: 10.1186/s12873-021-00539-8.
   PubMed Web of Science ®Google Scholar
• McCullough SA, Goyal P, Krishnan U, et al. Electrocardiographic findings in coronavirus disease-19: insights on mortality and underlying myocardial processes. J Card Fail. 2020;26(7):626–632. doi: 10.1016/j.cardfail.2020.06.005.
   PubMed Web of Science ®Google Scholar
• Chorin E, Wadhwani L, Magnani S, et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart Rhythm. 2020;17(9):1425–1433. doi: 10.1016/j.hrthm.2020.05.014.
   PubMed Web of Science ®Google Scholar
• Li R, Wang H, Ma F, et al. Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiography. Acta Pharmacol Sin. 2021;42(10):1567–1574. doi: 10.1038/s41401-020-00595-z.
   PubMed Web of Science ®Google Scholar
• Agricola E, Beneduce A, Esposito A, et al. Heart and lung multimodality imaging in COVID-19. JACC Cardiovasc Imaging. 2020;13(8):1792–1808. doi: 10.1016/j.jcmg.2020.05.017.
   PubMed Web of Science ®Google Scholar
• Szekely Y, Lichter Y, Taieb P, et al. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142(4):342–353. doi: 10.1161/CIRCULATIONAHA.120.047971.
   PubMed Web of Science ®Google Scholar
• Lei L, Maust DT. Delayed care related to COVID-19 in a nationally representative sample of older Americans. J Gen Intern Med. 2022;37(5):1337–1340. doi: 10.1007/s11606-022-07417-4.
   PubMed Web of Science ®Google Scholar
• Xie Y, Xu E, Bowe B, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583–590. doi: 10.1038/s41591-022-01689-3.
   PubMed Web of Science ®Google Scholar
• Huang C, Huang L, Wang Y, et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8.
   PubMed Web of Science ®Google Scholar